Replies to post #112371 on Biotech Values

[DewDiligence]

The conjecture in #msg-58508360 remains operative. If NVS/MNTA’s patent-infringement suit is not dismissed, legal discovery pursuant to the fact-finding of the case could prove embarrassing to Teva by showing that Teva never had a credible Lovenox program, but rather had been misleading the investment community for several years.

[DewDiligence]

…wasting more carbon on PPHM and their 'forays' in the clinic…

Allow me one more observation on PPHM’s HCV program which is apropos to my contention in #msg-58664917 that the planned phase-2 trial is unethical: the trial is being conducted entirely in Eastern Europe (Tbilisi, Georgia).

[DewDiligence]

Next, it'll be "enox-o-what?"

Exactly what happened—nice call.